Scientists at The Scripps Research Institute discover a previously unknown role for antibodies

September 06, 2001

La Jolla, CA, September 7, 2001 -- A team of scientists lead by Professor Richard Lerner, Ph.D., President of The Scripps Research Institute (TSRI) have discovered that antibodies have a novel catalytic ability--unique among proteins--which could possibly mean they do more to protect our bodies than scientists had previously thought.

In the current issue of the journal Science, the team demonstrates that antibodies can catalyze the formation of hydrogen peroxide from singlet oxygen.

All antibodies have the ability to do this," says Professors Paul Wentworth Jr., Ph.D. and Kim Janda, Ph.D., two of the lead authors on the paper. "Singlet oxygen is not something you want around."

Singlet oxygen is an electronically excited form of oxygen that forms spontaneously during normal metabolic processes or when oxygen is subjected to visible or ultraviolet light in the presence of a sensitizer. Singlet oxygen is highly reactive, making it potentially dangerous to an organism. Throughout evolution, animals have developed various mechanisms for removing singlet oxygen in order to survive. Also called immunoglobins, antibodies are produced by the immune system's B cells. The body has a large pool of B cells that recognize a wide range of foreign proteins, and after a pathogen enters the bloodstream, B cells produce specific antibodies that circulate through the blood and track down, bind to, and help eliminate the viral or bacterial invaders.

In the report, the team speculates that before this antibody-mediated immune response evolved in vertebrates hundreds of millions of years ago, an ancient form of antibodies may have existed--molecules whose role was to catalyze singlet oxygen destruction.

"Antibodies could have played a role as ancient proteins whose function was to remove singlet oxygen," says Janda.

The ability to convert oxygen into hydrogen peroxide may also be part of a previously unrecognized killing mechanism that would enhance the defensive role of antibodies by allowing them to subject pathogens to hydrogen peroxide and participate directly in their killing.

Lerner and Wentworth comment, "This heretofore unknown and intrinsic capacity of antibodies opens up exciting possibilities for new antibody-mediated therapies for conditions ranging from bacterial and viral infection to cancer. Furthermore, the ability of antibodies to generate toxic compounds may be linked to a number of autoimmune disease states, such as lupus."

Based on their examination of antibody and T-cell receptor x-ray crystal structures, the authors propose a conserved site within the antibody structure where they believe the singlet oxygen binds and where the catalytic process is initiated.

Another interesting finding is that the antibodies carry the reaction through an unusual intermediate called dihydrogen trioxide that is formed from the addition of water and oxygen. Dihydrogen trioxide has never before been observed in biological systems. "Although its presence has been a source of considerable speculation," says Wentworth.

The research article, "Antibodies Catalyze the Oxidation of Water" is authored by Paul Wentworth, Jr., Lyn H. Jones, Anita D. Wentworth, Xueyong Zhu, Nicholas A. Larsen, Ian A. Wilson, Xin Xu, William A. Goddard III, Kim D. Janda, Albert Eschenmoser, and Richard A. Lerner, and appears in the September 7, 2001 issue of the journal Science.
The research was funded in part by the National Institutes of Health and The Skaggs Institute for Chemical Biology.

Scripps Research Institute

Related Antibodies Articles from Brightsurf:

Scientist develops new way to test for COVID-19 antibodies
New research details how a cell-free test rapidly detects COVID-19 neutralizing antibodies and could aid in vaccine testing and drug discovery efforts.

Mussels connect antibodies to treat cancer
POSTECH research team develops innovative local anticancer immunotherapy technology using mussel protein.

For an effective COVID vaccine, look beyond antibodies to T-cells
Most vaccine developers are aiming solely for a robust antibody response against the SARS-CoV-2 virus, despite evidence that antibodies are not the body's primary protective response to infection by coronaviruses, says Marc Hellerstein of UC Berkeley.

Children can have COVID-19 antibodies and virus in their system simultaneously
With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.

The behavior of therapeutic antibodies in immunotherapy
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells.

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites
This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.

Neutralizing antibodies in the battle against COVID-19
An important line of defense against SARS-CoV-2 is the formation of neutralizing antibodies.

Three new studies identify neutralizing antibodies against SARS-CoV-2
A trio of papers describes several newly discovered human antibodies that target the SARS-CoV-2 virus, isolated from survivors of SARS-CoV-2 and SARS-CoV infection.

More effective human antibodies possible with chicken cells
Antibodies for potential use as medicines can be made rapidly in chicken cells grown in laboratories.

Read More: Antibodies News and Antibodies Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to